RCT | Efficacy and safety of Rituximab for new onset generalized Myasthenia Gravis.
21 Sep, 2022 | 13:04h | UTC
Commentary on Twitter
Treatment with #rituximab shortly after onset of #myastheniagravis was effective, a placebo-controlled randomized study showed. https://t.co/wdUzx7yOq6 #Research
— JAMA Neurology (@JAMANeuro) September 19, 2022